We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mass Spectrometry Accelerates Protein Biotherapeutics Discovery and Assures Quality Control

Article   Sep 27, 2019 | By Masha G. Savelieff, PhD.

 
Mass Spectrometry Accelerates Protein Biotherapeutics Discovery and Assures Quality Control

Credit: Pixabay

 
 
 

RELATED ARTICLES

Proteomics, "Zombie" Cells and Clinical Biomarkers of Aging

Article

In a new study scientists have harnessed advances in proteomics to extensively profile the secretions of senescent cells which are implicated in aging. Their analyses are collated in a database that is now available for researchers in the field.

READ MORE

The Importance of Understanding Target–Protein Interactions in Drug Discovery

Article

You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its mechanism of action? Drugs exhibit their effects through specific protein–target interactions. Andrew Lynn, Chief Executive Officer at Fluidic Analytics discusses why understanding protein–target interactions is so important.

READ MORE

Incidence vs Prevalence

Article

In epidemiology, prevalence and incidence are among the most fundamental measures when it comes to monitoring disease. But do you know what they mean or how and why they are important? This article takes a look at disease prevalence and incidence, what this information tells us and how it can be used.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE